Pharmaceutical Market in China: Policy Reform, Impacts and Opportunities

Introduction: The policy reform is expected to reshape the pharmaceutical market in China. In this presentation, we shall discuss the followings, but not limited to: •The reform streamlines the clinical trials approval process in China, how would it affect the clinical trial landscape? •What kind of drugs would potentially get expedited review and approval in China? •What pricing and reimbursement strategies were taken by generics manufactures and innovative drug developers under the downward pricing pressure? •What are the incentives for innovation? •How to capture and analysis the opportunities for 505(b)(2) drugs、pediatric drugs、orphan drugs、drugs with breakthrough designation?

Time:16:00~17:00 19 June (UTC+8)

Organizer: CPhI China

Co-organizer: Pharma Intelligence | Informa

Speakers